Clinical Trials Logo

Kidney Neoplasms clinical trials

View clinical trials related to Kidney Neoplasms.

Filter by:

NCT ID: NCT03867045 Terminated - Clinical trials for Metastatic Renal Cell Carcinoma Treated With Cabozantinib

Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal Cancer

Cabo App
Start date: August 21, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to develop an on-line electronic symptom management application that can ultimately be used to improve clinical outcomes in patients with mRCC treated with cabozantinib.

NCT ID: NCT03857373 Recruiting - Kidney Cancer Clinical Trials

Renal Cancer Detection Using Convolutional Neural Networks

RCCCNN
Start date: February 1, 2019
Phase:
Study type: Observational [Patient Registry]

We aim to experiment and implement various deep learning architectures in order to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, we are interested in detecting renal tumors from CT urography scans in this project. We would like to classify renal tumor to cancer, non cancer, renal cyst I, renal cyst II, renal cyst III and renal cyst VI, with high sensitivity and low false positive rate using various types of convolutional neural networks (CNN). This task can be considered as the first step in building CAD systems for renal cancer diagnosis. Moreover, by automating this task, we can significantly reduce the time for the radiologists to create large-scale labeled datasets of CT-urography scans.

NCT ID: NCT03852030 Completed - Prostate Cancer Clinical Trials

Mind-Body Health in Uro-Oncology: Research Study

Start date: July 2012
Phase: N/A
Study type: Interventional

In this study, the researchers will examine the effects of post-mindfulness intervention email and text messages to promote maintenance of intervention effects over time in a uro-oncology sample (clinically localized prostate, kidney, and bladder cancer) of patients and spouses.

NCT ID: NCT03849820 Terminated - Renal Cancer Clinical Trials

Open vs Robotic Assisted Partial Nephrectomy

OpeRa
Start date: March 12, 2019
Phase: N/A
Study type: Interventional

To demonstrate that Robotic-Assisted partial nephrectomy is superior to Open partial nephrectomy in reducing the number of 30 day post-operative complications (Clavien-Dindo Type I-V) for patients with intermediate to high complexity kidney tumors.

NCT ID: NCT03846128 Not yet recruiting - Clinical trials for Metastatic Kidney Cancer

Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer

BIOSUNTOX
Start date: August 2019
Phase:
Study type: Observational

Patients treated on the first line of Sunitinib-targeted therapy for metastatic kidney cancer. Collection of additional blood tubes during routine blood tests for patient follow-up, to evaluate the plasma concentration of Sunitinib and its active metabolite desethyl-Sunitinib (DES)

NCT ID: NCT03844399 Recruiting - Liver Cancer Clinical Trials

(3D) Ultrasound Imaging Liver and Kidney

Start date: October 3, 2020
Phase:
Study type: Observational

This study is to assess the addition of 3D ultrasound guidance during standard care ablation or biopsies of liver or kidney tumours. 3D ultrasound only differs from conventional 2D ultrasound in that the ultrasound transducer is mounted on a special assembly that moves the transducer in precise, stepped movements while a succession of 2D images are collected by the computer. Special software written specifically for 3D ultrasound precisely aligns these 2D images into a 3-demensional volume , allowing area in question to be viewed in many different planes. 3D ultrasound is a safe, fast, non-invasive imaging procedure. Ultrasound images will be checked against the pre- and post- procedure CT images to make sure the tumours were completely removed or properly targeted during biopsy.

NCT ID: NCT03841149 Completed - Clinical trials for Chronic Kidney Diseases

Volume 3D_US Kidney

VolUS3D
Start date: June 29, 2020
Phase:
Study type: Observational

The purpose of this study is to measure the volume of the kidney and tumors using 3D-US acquisition and to correlate these measurements to contrast-enhanced CT or MRI.

NCT ID: NCT03824808 Terminated - Prostate Cancer Clinical Trials

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

Start date: February 26, 2019
Phase: Phase 4
Study type: Interventional

Controlling pain is fundamental during and after surgical procedures. This study examines pain associated with robotic assisted surgery on prostate cancer or a kidney mass. In recent years, the risk of opioids in the postoperative period has gained interest due to the growing epidemic of addiction, dependence, and overdose. In this study, the investigators expect a continuous infusion of intravenous lidocaine during the perioperative period to result in less pain and less opioid use.

NCT ID: NCT03819569 Active, not recruiting - Kidney Tumor Clinical Trials

GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses

GRADE-SRM
Start date: October 30, 2018
Phase: N/A
Study type: Interventional

Purpose: The purpose of this study is to evaluate the role of renal mass biopsy on decision-making for patients presenting with clinical T1 kidney tumors. This study also incorporates integrated biomarker study to compare the genomic data obtained through biopsy tissue to genomic information from surgical data.

NCT ID: NCT03810651 Recruiting - Wilms Tumor Clinical Trials

Pencil Beam Scanning in Patients With Renal Tumors

Start date: December 26, 2017
Phase: Early Phase 1
Study type: Interventional

This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.